COVID-19 patients are experiencing long-term effects from the virus
August 13, 2020COVID, COVID-19, coronavirus
Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.
FDA approves NS Pharma’s Viltepso for Duchenne muscular dystrophy, but concerns over benefit persist
August 13, 2020Sales and Marketing Duchenne Muscular Dystrophy, FDA, NS pharma, Viltepso
NS Pharma has claimed a tentative FDA approval for its Viltepso (viltolarsen) injection in the treatment of Duchenne muscular dystrophy …
Coronavirus fake news has led to hundreds of deaths, according to a new study
August 13, 2020Medical Communications COVID, coronavirus, fake news
At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …
Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues
August 12, 2020Research and Development COVID-19, Gilead, pharma, remdesivir
New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …
Bristol Myers Squibb announces positive results from Opdivo clinical trials
August 12, 2020Research and Development Bristol-Myers Squibb, Cancer, bristol myers squibb
Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo. The first trial …
Mexico to hold trials for Chinese and American COVID-19 vaccines
August 12, 2020Research and Development COVID-19, Mexico, Mexico coronavirus
Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …
Moderna commits 100 million COVID-19 vaccine doses to the US
August 12, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma
Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …
Pharmafile.com’s weekly COVID-19 news round-up
August 12, 2020Research and Development COVID-19, coronavirus, covid news
The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …
Bayer scoops up women’s healthcare biotech KaNDy Therapeutics in potential $1bn+ deal
August 11, 2020Manufacturing and Production, Research and Development, Sales and Marketing Bayer, KaNDy Therapeutics, menopause, pharma
Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …
Roche’s entrolizumab disappoints at Phase 3 in moderately to severely active ulcerative colitis
August 11, 2020Manufacturing and Production, Research and Development Roche, etrolizumab, trial failure, ulcerative colitis
Roche has voiced its disappointment after its investigational therapy etrolizumab showed “mixed results” as a treatment for moderately to severely …
Gilead applies for FDA approval to treat coronavirus patients with remdesivir
August 11, 2020Manufacturing and Production COVID-19, Gilead, coronavirus
Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients. The drug would go under …
Arthritis drug Abatacept could be used to treat type 1 diabetes
August 11, 2020Manufacturing and Production diabetes, insulin, tye 1, type 2
People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds. Researchers at …
Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine
August 11, 2020Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus
President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …
Dr Christine Wilkinson Blanc appointed as Chief Medical Officer at Nordic Nanovector
August 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.
Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020
August 10, 2020Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine
More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …
Over a third of Americans say they won’t take a coronavirus vaccine
August 10, 2020Sales and Marketing COVID-19, coronavirus, vaccines
35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling. A new Gallup …
Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions
August 10, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine
Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …
FDA approves opioid Olinvyk for patients with acute pain
August 10, 2020Sales and Marketing opioid crisis, opioids
The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is …
Genentech’s Evrysdi becomes first FDA-approved oral treatment for spinal muscular atrophy
August 10, 2020Sales and Marketing Evrysdi, FDA, Genentech, Roche, spinal muscular atrophy
Genentech’s Evrysdi (risdiplam) has secured FDA approval for the treatment of spinal muscular atrophy (SMA), making it the first oral therapy …
Early promise from Novavax’s vaccine candidate for COVID-19
August 7, 2020Medical Communications, Research and Development COVID-19, Novavax, Vaccine
New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
